This is the last of a three-part series of tips for Parkinson’s Caregivers from Ageless Grace® (read Part 1 and Part 2). Eating to feed and nourish the Body and Brain is especially important for PD. Even though obesity itself is not a cause of Parkinson’s disease, it can be a limiting factor in how much movement is possible as the disease progresses.
Blog Introduction Text
Welcome to the National Parkinson Foundation's blog, where you can keep up-to-date on the latest research, read about what's hot in the Parkinson's community, learn caregiving tips and more.
The recent surge in publications on exercise for Parkinson’s disease has left many patients and doctors ill equipped to implement programs. Most of the exercise trials in Parkinson’s have revealed meaningful benefits both in Parkinson’s specific symptoms and in quality of life.
Parkinson’s disease patients frequently struggle to identify drug therapies that can address bothersome symptoms such as sleep dysfunction, bladder urgency, drooling, and tremor. Many of the drug therapies such as Benadryl (diphenhydramine), Advil PM, Alleve PM, common antihistamines, and others pills are readily available over the counter and do not require a prescription. These medications block a cholinergic receptor in the brain, and can improve many Parkinson’s disease symptoms.
This is the second of a three-part series of tips for Parkinson’s Caregivers from Ageless Grace®. Part 1 is here. Reducing stress is also a key area to consider with Parkinson’s, since stress has been known to aggravate Parkinson’s symptoms.
One surprising fact in DBS technology is that the human deep brain stimulation (DBS) leads and the four shiny and tiny contacts on them have surprisingly not significantly changed for the last two decades. One reason for the durability of DBS lead design has been the long-term beneficial effects of utilizing this simple approach. There are however, compelling reasons to introduce new DBS lead designs into clinical practice.
Finding the right exercise program is extremely important for PD which is characterized by movement disorders such as slow or shuffling walk, tremors in the hands, fingers, forearms, feet, mouth, or chin, rigid or stiff muscles, including muscles that suddenly freeze for no reason, muscle pain and unsteady gait and balance.
Recently there has been a surge of interest in cholesterol and cholesterol lowering drugs (statins) and the risk of developing Parkinson’s disease (PD). Patients and families with a personal interest in the outcomes of these studies simply want to know whether they should consider starting a statin medication or they should change their diet. In this month's What’s Hot column we will examine the evidence and offer a recommendation for those considering a statin drug.
One of the common dreams shared by Parkinson’s disease patients around the globe is the possibility of living a pill free existence, and one year ago we shared the news of a therapy coming to the United States with the possibility to make this a reality for a select group of patients. This month we will update the previous blog post from 2014, and bring to you all of the information you need to know about the therapy. The therapy has received a full FDA approval and
The What’s Hot in Parkinson’s disease blog written in April 2013 featured a new extended release dopamine drug called IPX066. This new dopamine formulation achieved full FDA approval in January 2015. The drug is now sold under the name Rytary. At National Parkinson Foundation we frequently hear from Parkinson’s disease patients that current carbidopa/levodopa medication preparations fail to adequately address disease-related symptoms.
Considerable evidence has been mounting supporting a relationship between the gastrointestinal system and Parkinson’s disease. Many pathologists and neurologists believe that Parkinson’s disease may start in the gut, however this view remains speculative. Additionally, there are many GI symptoms such as constipation that occur as prominent and disabling features of Parkinson’s disease.